Two Sigma Investments’s BioNexus Gene Lab BGLC Stock Holding History

Two Sigma Investments’s Portfolio BGLC Stock Details BGLC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,553	Closed	-$8.4K	–	3191
2025 Q1	$8.4K	Buy	+3,553	New	+$12.5K	﹤0.01%	3137

Other funds holding BGLC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's BGLC Position: Q2 2025 in Review

Two Sigma Investments sold out of BioNexus Gene Lab (BGLC) in Q2 2025, closing a stake of 3,553 shares — an estimated $8.4K sold.

Two Sigma Investments first reported a position in BGLC in Q1 2025 and held it in 1 quarter. The position peaked at $8.4K in Q1 2025. 1 fund tracked by Wall St. Rank holds BGLC as of Q2 2025.

Two Sigma Investments reported no remaining BioNexus Gene Lab position as of Q2 2025 after selling out during the quarter.
Two Sigma Investments sold 3,553 BioNexus Gene Lab shares in Q2 2025, an estimated $8.4K.
Two Sigma Investments first reported a position in BioNexus Gene Lab in Q1 2025 and held it in 1 quarter.
Two Sigma Investments's BioNexus Gene Lab position peaked at $8.4K in Q1 2025.
1 fund tracked by Wall St. Rank held BioNexus Gene Lab as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.